Inhibition of mesothelin as a novel strategy for targeting cancer cells. - Test2 - elhamkhani - TriplyDB

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

http://www.wikidata.org/entity/Q34224746

about

Clinical impacts of mesothelin expression in gastrointestinal carcinomas Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice.Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts Incorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy.Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing.Unique cellular interactions between pancreatic cancer cells and the omentum Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.Ovarian cancer stroma: pathophysiology and the roles in cancer development.Mesothelin expression and survival outcomes in triple receptor negative breast cancer.MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.Overexpression of sulfatase-1 in murine hepatocarcinoma Hca-F cell line downregulates mesothelin and leads to reduction in lymphatic metastasis, both in vitro and in vivo C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.Mesothelin promotes invasion and metastasis in breast cancer cells.RalA is overactivated in medulloblastoma.Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.Malignant mesothelioma: development to therapy Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.Trial watch: Chemotherapy with immunogenic cell death inducers.The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment

P2860

Q26748680-E96117D3-E8F0-4327-B066-BB35D00CA43D Q29048401-075C17C6-E2D7-4601-9A9F-EEDECEE89B38 Q33929696-C69F16C3-8F4B-42A7-9AFD-8F2F033A78BF Q34278435-931A479C-428A-481E-832A-7E34740FF259 Q34984956-21A34867-1DF4-4DCC-84CC-7C6A6D95CF5C Q35620238-B2A15C95-372A-47F7-9BE2-8FB0B32E00B9 Q36261542-5653B79D-50CC-4CAA-AD48-8B0AF50DE15A Q36410426-8C580D84-C58D-4003-86AC-2D8AC451B9D6 Q36864971-5B0883FE-8EA3-4E1F-99CD-CD52AF466A3F Q37017056-98424F86-1F1E-483B-8A93-9A6A49436B19 Q37339008-E9B0C365-0BA5-4CC0-BA6D-D9DE75883BF8 Q37499806-83DBEF6C-259C-46B1-B78F-F4692326707A Q37688894-0DD6EF38-6C44-40BE-BECB-3C86CF895C54 Q39178281-35E7ECB8-ECAE-4917-8876-0E029D78F596 Q39210075-7160D3C6-6517-4033-8F32-C69BD71D55FB Q39449209-D580271B-C7A4-4603-81E6-FD090A023980 Q41234207-98CD81AA-8DEC-4902-BEBE-C19D9D6617A4 Q41967712-74D10BEE-8B00-4F50-8846-4FA0C68AE09F Q47309343-44BE3470-E511-4F9A-A8AD-33344CCBE518 Q55658029-0713B976-D2C0-4349-A117-3FC7C03B2FEE Q58726271-1FE4B590-9DB8-4635-8F07-57D92651CD99

P2860

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

http://www.wikidata.org/entity/Q34224746

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@ast

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@en

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@nl

type

label

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@ast

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@en

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@nl

prefLabel

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@ast

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@en

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@nl

P1433

Q34224746-C4810AED-84E2-4B78-B816-23D3B1DBD2CC

P1476

Q34224746-2FB5DE91-1BDF-4CB1-A8E8-70715A79DEBA

P2093

Q34224746-000AC0F2-A3F3-4071-AE9B-751B935D383E

Q34224746-05E365C5-1203-4672-B516-9D31765E8F6C

Q34224746-204C1CBD-EDF8-4FB9-9069-B9CD34B927B6

Q34224746-2D658D09-96E3-47C4-86FA-26EFA24C3391

Q34224746-306BAC5B-B5D7-40C0-9893-C22C41E57A02

Q34224746-3736947C-7C63-42A5-ADE2-382B753FE8FF

Q34224746-4B223FDF-9133-4D5F-8430-14A0F6D31575

Q34224746-87B5E040-35B7-419A-AB75-9A153ECA607C

Q34224746-917210F6-3BA0-46F9-9A8E-481644C280EB

Q34224746-B98DBA0A-737C-459A-9AD2-DE6C5C2EFA7C

P2860

Q34224746-0186B687-8130-4A67-BE99-2B6E3F885C21

Q34224746-0353FDA2-BD0A-4196-8E93-1CCBCB13730A

Q34224746-05B9D19B-0EC2-4240-B22D-9A524CECD12E

Q34224746-086900C8-8CC0-46FD-ABD9-976B8FF0C8EF

Q34224746-0A12B316-734A-4F54-9E07-68FBE1CF1DBE

Q34224746-0AD47658-671A-496D-8423-A5AF8130501C

Q34224746-0B4B9F91-788E-4E9F-BF42-B5DB76ECBBD8

Q34224746-1055E6F0-93AE-4339-8965-15E7B483EEC2

Q34224746-13B78894-AEC0-490F-A531-989F72DC210F

Q34224746-18C25492-AFAA-404D-8DD9-70682DD098F6

P304

Q34224746-A46D8E2E-F2C1-4147-90F5-B79DC5EB9FC4

P31

Q34224746-A65D9A95-991F-47E9-AC19-6CF0D0E45621

P356

Q34224746-4A24FDC2-A2BE-4D88-B047-C97CF9359240

P407

Q34224746-137C42A6-2605-45D3-9AC5-0D74068C045A

P433

Q34224746-150DD873-9334-40A8-80EB-84A61CAB05F2

P478

Q34224746-8BEAE320-EBFA-4632-8633-5A68661B29C5

P577

Q34224746-F0968C52-2607-42B5-8B55-D1A6247C7A5C

P5875

Q34224746-35CB9555-A1AF-4B97-A2D5-9281CF803D43

P698

Q34224746-C541BC54-D328-4C28-A0DA-12F6D333CC31

P932

Q34224746-26767B33-E038-4F48-85E5-FBD855DFCDB6

P356

JOURNAL.PONE.0033214

P1433

P1476

Inhibition of mesothelin as a novel strategy for targeting cancer cells.

@en

P2093

Anna Meyer

http://www.w3.org/2001/XMLSchema#string

Arkadiusz Z Dudek

http://www.w3.org/2001/XMLSchema#string

Emma Borrego-Diaz

http://www.w3.org/2001/XMLSchema#string

Faris Farassati

http://www.w3.org/2001/XMLSchema#string

Farnaz Yamoutpoor

http://www.w3.org/2001/XMLSchema#string

Kun Wang

http://www.w3.org/2001/XMLSchema#string

Mojtaba S Olyaee

http://www.w3.org/2001/XMLSchema#string

Richard A Woo

http://www.w3.org/2001/XMLSchema#string

Tuba Esfandyari

http://www.w3.org/2001/XMLSchema#string

Vidya Bodempudi

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion

Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers

MicroRNAs: target recognition and regulatory functions

Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression

Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors

Characterization of human mesothelin transcripts in ovarian and pancreatic cancer

Stromelysin-1 and mesothelin are differentially regulated by Wnt-5a and Wnt-1 in C57mg mouse mammary epithelial cells

Origins and Mechanisms of miRNAs and siRNAs

The tuberin-hamartin complex negatively regulates beta-catenin signaling activity

The Ras-Raf-MEK-ERK pathway in the treatment of cancer

P304

e33214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0033214

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223966580

http://www.w3.org/2001/XMLSchema#string

P698

22485139

http://www.w3.org/2001/XMLSchema#string

P932

3317639

http://www.w3.org/2001/XMLSchema#string